drugset / Trial / NCT00104117
Study of XL999 in Adults With Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability of XL999 in adults with advanced solid tumors.
Timeline
- Start
- 2004-11
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XL999 | Small molecule | 0.2 mg/kg | Intravenous |
| Subject | XL999 | Small molecule | 200 mg | Intravenous |